We came across a bullish thesis on Edwards Lifesciences Corporation on Natan’s Substack. In this article, we will summarize the bulls’ thesis on EW. Edwards Lifesciences Corporation’s share was trading at $76.05 as of September 15th. EW’s trailing and forward P/E were 31.82 and 28.17 respectively according to Yahoo Finance.
Jirsak/Shutterstock.com
Edwards Lifesciences, the global leader in heart valve therapies, delivered strong Q2 results that marked a return to double-digit...
